Tóm tắt

Tài liệu tham khảo

• [1] B. L. Price, R. Morley, F. L. Bowling, A. M. Lovering, and C. B. Dobson. (2020). "Susceptibility of Monomicrobial or Polymicrobial Biofilms Derived from Infected Diabetic Foot Ulcers to Topical or Systemic Antibiotics In Vitro". PLoS One. 15 (2): 1-14. 10.1371/journal.pone.0228704.

  DOI: https://doi.org/10.1371/journal.pone.0228704

• [2] N. Safitri, D. Kusumaningrum, A. D. Saputri, and H. Kusuma. (2020). "Karakteristik Diabetic Foot Ulcer (DFU) pada Individu dengan Diabetes Mellitus (DM): Studi Deskriptif Cross-Sectional". Journal of Holistic Nursing Science. 7 (2): 88-98. 10.31603/nursing.v7i2.3074.

  DOI: https://doi.org/10.31603/nursing.v7i2.3074

• [3] P. Zhang, J. Lu, Y. Jing, S. Tang, D. Zhu, and Y. Bi. (2017). "Global Epidemiology of Diabetic Foot Ulceration: A Systematic Review and Meta-Analysis". Annals of Medicine. 49 (2): 106-116. 10.1080/07853890.2016.1231932.

  DOI: https://doi.org/10.1080/07853890.2016.1231932

• [4] Hardani, H. Soonmin, K. Syahidi, A. Zaidah, Sulistiyana, A. Hidayatulloh, A. Fudholi, and L. M. Angraini. (2021). "Non-Vascular Contributing Factors of Diabetic Foot Ulcer Severity in a National Referral Hospital of Indonesia". Journal of Diabetes and Metabolic Disorders. 20 (1): 805-813. 10.1007/s40200-021-00827-x.

  DOI: https://doi.org/10.1007/s40200-021-00827-x

• [5] Y. Sari, A. S. Upoyo, A. Isworo, A. Taufik, A. Sumeru, D. Anandari, and E. Sutrisna. (2020). "Foot Self-Care Behavior and Its Predictors in Diabetic Patients in Indonesia". BMC Research Notes. 13 (1): 4-9. 10.1186/s13104-020-4903-y.

  DOI: https://doi.org/10.1186/s13104-020-4903-y

• [6] S. Dörr, A. K. Holland-Letz, G. Weisser, A. Chatzitomaris, and R. Lobmann. (2023). "Bacterial Diversity, Antibiotic Resistance, and the Risk of Lower Limb Amputation in Younger and Older Individuals with Diabetic Foot Infection". International Journal of Lower Extremity Wounds. 22 (1): 63-71. 10.1177/1534734621992290.

  DOI: https://doi.org/10.1177/1534734621992290

• [7] W. F. Mohamed, A. A. Askora, M. M. H. Mahdy, E. A. El-Hussieny, and H. M. Abu-Shady. (2022). "Isolation and Characterization of Bacteriophages Active against Pseudomonas aeruginosa Strains Isolated from Diabetic Foot Infections". Archives of Razi Institute. 77 (6): 2187-2200. 10.22092/ARI.2022.359032.2357.

• [8] C. J. Grace and M. A. Ricci.(2020)." Diabetic Foot Infections. 581-598.

• [9] Idris, Z. Palisoa, and A. Ernawati. (2020). "Pola Resistensi Bakteri pada Ulkus Diabetik". 140-143.

• [10] A. M. Frey, D. Chaput, and L. N. Shaw. (2021). "Insight into the Human Pathodegradome of the V8 Protease from Staphylococcus aureus". Cell Reports. 35 (1): 108930. 10.1016/j.celrep.2021.108930.

  DOI: https://doi.org/10.1016/j.celrep.2021.108930

• [11] S. Roy, S. Santra, A. Das, S. Dixith, M. Sinha, S. Ghatak, N. Ghosh, P. Banerjee, S. Khanna, S. Mathew-Steiner, P. D. Ghatak, B. N. Blackstone, H. M. Powell, V. K. Bergdall, D. J. Wozniak, and C. K. Sen. (2020). "Staphylococcus aureus Biofilm Infection Compromises Wound Healing by Causing Deficiencies in Granulation Tissue Collagen". Annals of Surgery. 271 (6): 1174-1185. 10.1097/SLA.0000000000003053.

  DOI: https://doi.org/10.1097/SLA.0000000000003053

• [12] K. S. Hardy, M. H. Tessmer, D. W. Frank, and J. P. Audia. (2021). "Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection". Toxins. 13 (12).  10.3390/toxins13120880.

  DOI: https://doi.org/10.3390/toxins13120880

• [13] K. Jeyaraman, T. Berhane, M. Hamilton, A. P. Chandra, and H. Falhammar. (2019). "Amputations in Patients with Diabetic Foot Ulcer: A Retrospective Study from a Single Centre in the Northern Territory of Australia". ANZ Journal of Surgery. 89 (7): 874-879. 10.1111/ans.15351.

  DOI: https://doi.org/10.1111/ans.15351

• [14] A. M. Pinto, M. A. Cerqueira, M. Bañobre-López, L. M. Pastrana, and S. Sillankorva. (2020). "Bacteriophages for Chronic Wound Treatment: From Traditional to Novel Delivery Systems". Viruses. 12 (2): 235. 10.3390/v12020235.

  DOI: https://doi.org/10.3390/v12020235

• [15] M. R. Yani, D. I. N. Pratiwi, Rahmiati, N. Muthmainah, and A. Yasmina. (2021). "Antibiotics Susceptibility Pattern in Diabetic Ulcer Patients". Indonesian Journal of Clinical Pathology and Medical Laboratory. 27 (2): 205-211. 10.24293/ijcpml.v27i2.1652.

  DOI: https://doi.org/10.24293/ijcpml.v27i2.1652

• [16] C. Uruén, G. Chopo-Escuin, J. Tommassen, R. C. Mainar-Jaime, and J. Arenas. (2021). "Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance". Antibiotics. 10 (1): 1-36. 10.3390/antibiotics10010003.

  DOI: https://doi.org/10.3390/antibiotics10010003

• [17] K. Azeem, S. Fatima, A. Ali, A. Ubaid, F. M. Husain, and M. Abid. (2025). "Biochemistry of Bacterial Biofilm: Insights into Antibiotic Resistance Mechanisms and Therapeutic Intervention". Life. 15 (1): 1-23. 10.3390/life15010049.

  DOI: https://doi.org/10.3390/life15010049

• [18] S. Singh, S. Datta, K. B. Narayanan, and K. N. Rajnish. (2021). "Bacterial Exopolysaccharides in Biofilms: Role in Antimicrobial Resistance and Treatments". Journal of Genetic Engineering and Biotechnology. 19 (1). 10.1186/s43141-021-00242-y.

  DOI: https://doi.org/10.1186/s43141-021-00242-y

• [19] B. Singh, M. Dahiya, V. Kumar, A. Ayyagari, D. N. Chaudhari, and J. J. Ahire. (2025). "Biofilm and Antimicrobial Resistance: Mechanisms, Implications, and Emerging Solutions". Microbiological Research. 16 (8): 1-24. 10.3390/microbiolres16080183.

  DOI: https://doi.org/10.3390/microbiolres16080183

• [20] M. Dostert, M. J. Trimble, and R. E. W. Hancock. (2021). "Antibiofilm Peptides: Overcoming Biofilm-Related Treatment Failure". RSC Advances. 11 (5): 2718-2728. 10.1039/D0RA09739J.

  DOI: https://doi.org/10.1039/D0RA09739J

• [21] H. Ray, C. Weis, C. Nwaeze, V. Zhou, P. Basu, and A. Mitra. (2025). "Development and Control of Biofilms in Diabetic Foot Infections: A Narrative Review". Acta Microbiologica Hellenica. 70 (1). 10.3390/amh70010009.

  DOI: https://doi.org/10.3390/amh70010009

• [22] N. Tirumala and L. R. K. (2025). "Bacteriological Profile of Diabetic Foot Ulcer with Special Reference to Biofilm Formation". Cureus. 17 (3). 10.7759/cureus.80974.

  DOI: https://doi.org/10.7759/cureus.80974

• [23] S. F. Hamid, A. B. Taha, and M. J. Abdulwahid. (2020). "Distribution of blaTEM, blaSHV, blaCTX-M, blaOXA, and blaDHA in Proteus mirabilis Isolated from Diabetic Foot Infections in Erbil, Iraq". Cellular and Molecular Biology. 66 (1): 88-94. 10.14715/cmb/2019.66.1.15.

  DOI: https://doi.org/10.14715/cmb/2019.66.1.15

• [24] D. M. Khan, V. I. Rao, M. S. Moosabba, D. MubarakAli, and M. Manzoor. (2025). "Antimicrobial Resistance and Prevalence of β-Lactamase Genes among Multidrug-Resistant Acinetobacter baumannii Isolates from Infected Diabetic Foot Ulcers". Bacteria. 4 (2): 1-10. 10.3390/bacteria4020024.

  DOI: https://doi.org/10.3390/bacteria4020024

• [25] R. Zambelli, A. F. Santos, L. R. Moreira, H. M. Ribeiro, R. Simões, J. M. Magalhães, P. Constantino, M. C. Salomão, Cesar, and A. O. Leopoldino. (2025). "Bacterial Profile and Antimicrobial Resistance in Diabetic Foot Ulcer Infections: A 10-Year Retrospective Cohort Study". Brazilian Journal of Infectious Diseases. 29 (5).  10.1016/j.bjid.2025.104570.

  DOI: https://doi.org/10.1016/j.bjid.2025.104570

• [26] F. W. Wada, M. F. Mekonnen, E. D. Sawiso, S. Kolato, L. Woldegiorgis, G. K. Kera, Z. El-Khatib, A. A. Ashuro, M. Biru, and M. T. Boltena. (2023). "Bacterial Profile and Antimicrobial Resistance Patterns of Infected Diabetic Foot Ulcers in Sub-Saharan Africa: A Systematic Review and Meta-Analysis". Scientific Reports. 13 (1): 1-10. 10.1038/s41598-023-41882-z.

  DOI: https://doi.org/10.1038/s41598-023-41882-z

• [27] A. Ernawati, I. Rusmana, A. Wahyudi, S. Murtini, and S. Budiarti. (2025). "Hemolysin-Based Screening of Bacterial Pathogens in Patients with Diabetic Ulcers". 1550. 10.1088/1755-1315/1550/1/012026

  DOI: https://doi.org/10.1088/1755-1315/1550/1/012026

• [28] R. A. Khanam, M. R. Islam, A. Sharif, R. Parveen, I. Sharmin, and M. A. Yusuf. (2018). "Bacteriological Profiles of Pus with Antimicrobial Sensitivity Pattern at a Teaching Hospital in Dhaka City". Bangladesh Journal of Infectious Diseases. 5 (1): 10-14. 10.3329/bjid.v5i1.37710.

  DOI: https://doi.org/10.3329/bjid.v5i1.37710

• [29] A. M. Ghanaim, M. A. Foaad, E. Z. Gomaa, K. G. E. Mohamed, A. H. Arisha, and T. Khamis. (2023). "Bacteriophage Therapy as an Alternative Technique for Treatment of Multidrug-Resistant Bacteria Causing Diabetic Foot Infection". International Microbiology. 26 (2): 343-359. 10.1007/s10123-022-00293-2.

  DOI: https://doi.org/10.1007/s10123-022-00293-2

• [30] P. H. Krumperman. (1983). "Multiple Antibiotic Resistance Indexing of Escherichia coli to Identify High-Risk Sources of Faecal Contamination of Water". Applied and Environmental Microbiology. 46 (1): 165-170. 10.1128/aem.46.1.165-170.1983.

  DOI: https://doi.org/10.1128/aem.46.1.165-170.1983

• [31] R. Mir, S. Salari, M. Najimi, and A. Rashki. (2022). "Determination of Frequency, Multiple Antibiotic Resistance Index, and Resistotype of Salmonella spp. in Chicken Meat Collected from Southeast of Iran". Veterinary Medicine and Science. 8 (1): 229-236. 10.1002/vms3.647.

  DOI: https://doi.org/10.1002/vms3.647

• [32] E. F. Haney, M. J. Trimble, and R. E. W. Hancock. (2021). "Microtiter Plate Assays to Assess Antibiofilm Activity against Bacteria". Nature Protocols. 16 (5): 2615-2632. 10.1038/s41596-021-00515-3.

  DOI: https://doi.org/10.1038/s41596-021-00515-3

• [33] S. Stepanović, D. Vuković, V. Hola, G. D. Bonaventura, S. Djukić, I. Ćirković, and F. Ruzicka. (2007). "Salmonella enterica Serovar Dublin from Cattle in California from 1993–2019: Antimicrobial Resistance Trends of Clinical Relevance". APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica. 115 (8): 889-891. 10.1111/j.1600-0463.2007.apm_630.x.

  DOI: https://doi.org/10.1111/j.1600-0463.2007.apm_630.x

• [34] M. G. Donadu, M. Ferrari, V. Mazzarello, S. Zanetti, I. Kushkevych, S. K. M. R. Rittmann, A. Stájer, Z. Baráth, D. Szabó, E. Urbán, and M. Gajdács. (2022). "No Correlation between Biofilm-Forming Capacity and Antibiotic Resistance in Environmental Staphylococcus spp.: In Vitro Results". Pathogens. 11 (4).  10.3390/pathogens11040471.

  DOI: https://doi.org/10.3390/pathogens11040471

• [35] E. Di Domenico, I. Farulla, G. Prignano, M. Gallo, M. Vespaziani, I. Cavallo, I. Sperduti, M. Pontone, V. Bordignon, L. Cilli, A. De Santis, F. Di Salvo, F. Pimpinelli, I. Lesnoni La Parola, L. Toma, and F. Ensoli. (2017). "Biofilm Is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug-Resistant Phenotype". International Journal of Molecular Sciences. 18 (5).  10.3390/ijms18051077.

  DOI: https://doi.org/10.3390/ijms18051077

• [36] G. Geneaid. (2017). "Presto Mini gDNA Bacteria Kit". Geneaid Biotech Ltd. 1-8.

• [37] A. T. Nguyen, T. C. Phan, T. B. Ngo, T. T. Nguyen, L. T. Ho, M. T. Quang, and T. M. Nguyen. (2025). "Multiplex PCR for Identification and β-Lactam Resistance Gene Detection in Clinical Isolates of Acinetobacter baumannii". Journal of Infection in Developing Countries. 19 (5): 723-731. 10.3855/jidc.20664.

  DOI: https://doi.org/10.3855/jidc.20664

• [38] H. Arabi, I. Pakzad, A. Nasrollahi, H. Hosainzadegan, F. Azizi Jalilian, M. Taherikalani, N. Samadi, and A. Monadi Sefidan. (2015). "Sulfonamide Resistance Genes (sul) in Extended-Spectrum β-Lactamase (ESBL) and Non-ESBL Producing Escherichia coli Isolated from Iranian Hospitals". Jundishapur Journal of Microbiology. 8 (7). 10.5812/jjm.19961v2.

  DOI: https://doi.org/10.5812/jjm.19961v2

• [39] J. R. Marchesi, T. Sato, A. J. Weightman, T. A. Martin, J. C. Fry, S. J. Hiom, D. Dymock, and W. G. Wade. (1998). "Design and Evaluation of Useful Bacterium-Specific PCR Primers That Amplify Genes Coding for Bacterial 16S rRNA". Applied and Environmental Microbiology. 64 (6): 2333-2339. 10.1128/AEM.64.6.2333-2333.1998.

  DOI: https://doi.org/10.1128/AEM.64.6.2333-2333.1998

• [40] S. F. Altschul, W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. (1990). "Basic Local Alignment Search Tool". Journal of Molecular Biology. 215 (3): 403-410. 10.1016/S0022-2836(05)80360-2.

  DOI: https://doi.org/10.1016/S0022-2836(05)80360-2

• [41] O. Oxoid. (2022). "Eosin Methylene Blue Agar: Instructions for Use (IFU-0533)". Oxoid Ltd. 1-39.

• [42] M. Millipore. (1970). "Cetrimide Agar: Pseudomonas Selective Agar Base (According to EP/USP/JP)". Merck Millipore.

• [43] M. Merck. (1945). "Mannitol Salt Agar – LI". Merck KGaA. 120-122.

• [44] Y. Qu, S. Ou, W. Zhang, J. Li, C. Xia, Y. Yang, J. Liu, Y. Ma, N. Jiang, Y. Wang, B. Chen, B. Yu, Y. Qi, and C. Xu. (2024). "Microbiological Profile of Diabetic Foot Infections in China and Worldwide: A 20-Year Systematic Review". Frontiers in Endocrinology. 15. 10.3389/fendo.2024.1368046.

  DOI: https://doi.org/10.3389/fendo.2024.1368046

• [45] T. E. C. J. Huwae, I. Ratridewi, Y. M. Lena, D. Retnoningsih, P. Sananta, and S. Asmiragani. (2023). "Culture and Sensitivity Pattern of Aerobic Bacterial Isolates in Diabetic Foot Infections during 2018–2022 in Asian Countries: A Literature Review Study". Annals of Medicine and Surgery. 85 (2): 161-165. 10.1097/MS9.0000000000000223.

  DOI: https://doi.org/10.1097/MS9.0000000000000223

• [46] P. Baral, N. Afnan, M. A. Zahra, B. Akter, S. R. Prapti, M. M. Hossan, and F. Fahim. (2024). "Bacteriological Analysis and Antibiotic Resistance in Patients with Diabetic Foot Ulcers in Dhaka". PLoS One. 19 (5): 1-23. 10.1371/journal.pone.0301767.

  DOI: https://doi.org/10.1371/journal.pone.0301767

• [47] T. C. Goh, M. Y. Bajuri, S. C. Nadarajah, A. H. Abdul Rashid, S. Baharuddin, and K. S. Zamri. (2020). "Clinical and Bacteriological Profile of Diabetic Foot Infections in a Tertiary Care Centre". Journal of Foot and Ankle Research. 13 (1): 1-8. 10.1186/s13047-020-00406-y.

  DOI: https://doi.org/10.1186/s13047-020-00406-y

• [48] K. Rangel, G. C. Lechuga, D. W. Provance, C. M. Morel, and S. G. De Simone. (2023). "An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections". Pharmaceuticals. 16 (9). 10.3390/ph16091281.

  DOI: https://doi.org/10.3390/ph16091281

• [49] F. Du, J. Ma, H. Gong, R. Bista, P. Zha, Y. Ren, Y. Gao, D. Chen, X. Ran, and C. Wang. (2022). "Microbial Infection and Antibiotic Susceptibility of Diabetic Foot Ulcer in China: Literature Review". Frontiers in Endocrinology. 13.  10.3389/fendo.2022.881659.

  DOI: https://doi.org/10.3389/fendo.2022.881659

• [50] B. Coşkun, M. Ayhan, S. Ulusoy, and R. Guner. (2024). "Bacterial Profile and Antimicrobial Resistance Patterns of Diabetic Foot Infections in a Major Research Hospital of Turkey". Antibiotics. 13 (7). 10.3390/antibiotics13070599.

  DOI: https://doi.org/10.3390/antibiotics13070599

• [51] R. A. Afunwa, J. Ezeanyinka, E. C. Afunwa, A. S. Udeh, A. N. Oli, and M. Unachukwu. (2020). "Multiple Antibiotic Resistant Index of Gram-Negative Bacteria from Bird Droppings in Two Commercial Poultries in Enugu, Nigeria". Open Journal of Medical Microbiology. 10 (4): 171-181. 10.4236/ojmm.2020.104015.

  DOI: https://doi.org/10.4236/ojmm.2020.104015

• [52] D. O. Isaiah, K. Otokunefor, and O. E. Agbagwa. (2025). "Multiple Antibiotic Resistance Indexing and Molecular Identification of Escherichia coli Isolated from Clinical and Nonclinical Sources in Port Harcourt Metropolis, Nigeria". Pan African Medical Journal. 51 : 1-12. 10.11604/pamj.2025.51.11.38524.

  DOI: https://doi.org/10.11604/pamj.2025.51.11.38524

• [53] S. Kainat, M. Sohail, S. Rafique, M. Mustafa, and U. Ejaz. (2025). "Prevalence of Multidrug-Resistant Biofilm-Forming Pathogens in Diabetic Foot Ulcers and Antimicrobial Activity of Nanoparticles". Journal of Infection in Developing Countries. 19 (7): 1055-1065. 10.3855/jidc.21000.

  DOI: https://doi.org/10.3855/jidc.21000

• [54] C. Pouget, C. Dunyach-Remy, A. Pantel, S. Schuldiner, A. Sotto, and J. P. Lavigne. (2020). "Biofilms in Diabetic Foot Ulcers: Significance and Clinical Relevance". Microorganisms. 8 (10): 1580. 10.3390/microorganisms8101580.

  DOI: https://doi.org/10.3390/microorganisms8101580

• [55] A. C. Afonso, D. Oliveira, M. J. Saavedra, A. Borges, and M. Simões. (2021). "Biofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies". International Journal of Molecular Sciences. 22 (15). 10.3390/ijms22158278.

  DOI: https://doi.org/10.3390/ijms22158278

• [56] D. G. Armstrong, M. E. Edmonds, and T. E. Serena. (2023). "Point-of-Care Fluorescence Imaging Reveals Extent of Bacterial Load in Diabetic Foot Ulcers". International Wound Journal. 20 (2): 554-566. 10.1111/iwj.14080.

  DOI: https://doi.org/10.1111/iwj.14080

• [57] E. Nathaniel, J. Ikram, A. James, B. Obaid, A. Zahid, Z. Ahmed, D. K. Wazir, G. Qazi, G. Varrassi, S. Kumar, and M. Khatri. (2023). "Molecular Characterization and Antibiotic Susceptibility Pattern of Bacterial Strains Isolated from Wounds of Patients with Diabetes". Cureus. 15 (10). 10.7759/cureus.47681.

  DOI: https://doi.org/10.7759/cureus.47681

• [58] F. R. Almashhady, S. S. A. Al-Ameer, H. Mohammed, H. Al-Aaraji, and K. F. Abbas. (2024). "Molecular Detection of Beta-Lactamase Genes (KPC and CTX-M) of Pseudomonas aeruginosa in Diabetic Foot Ulcer Patients". Medical Science Journal Asian Research. 5 (3): 1-9. 10.46966/msjar.v5i3.225.

  DOI: https://doi.org/10.46966/msjar.v5i3.225

• [59] P. Leroux, C. Bornet, J. M. Bolla, and A. Cohen. (2025). "Challenges of Carbapenem-Resistant Enterobacteriaceae in the Development of New β-Lactamase Inhibitors and Antibiotics". Antibiotics. 14 (6): 1-14. 10.3390/antibiotics14060587.

  DOI: https://doi.org/10.3390/antibiotics14060587

• [60] T. Sawa, K. Kooguchi, and K. Moriyama. (2020). "Molecular Diversity of Extended-Spectrum β-Lactamases and Carbapenemases, and Antimicrobial Resistance". Journal of Intensive Care. 8 (1): 1-13. 10.1186/s40560-020-0429-6.

  DOI: https://doi.org/10.1186/s40560-020-0429-6

• [61] S. Alfei and A. M. Schito. (2022). "β-Lactam Antibiotics and β-Lactamase Enzyme Inhibitors, Part 2: Our Limited Resources". Pharmaceuticals. 15 : 476. 10.3390/ph15040476.

  DOI: https://doi.org/10.3390/ph15040476

• [62] N. M. Lukey and F. M. Abbas. (2021). "Genotypic Detection of GES and VEB Extended-Spectrum β-Lactamase among Aerobic Gram-Negative Bacteria Isolated from Diabetic Foot Ulcers". 790 : 012054. 10.1088/1755-1315/790/1/012054

  DOI: https://doi.org/10.1088/1755-1315/790/1/012054

• [63] M. Sadek, A. M. Saad, P. Nordmann, and L. Poirel. (2022). "Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) Escherichia coli Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA Methylase". Antibiotics. 11 (11): 1479. 10.3390/antibiotics11111479.

  DOI: https://doi.org/10.3390/antibiotics11111479

• [64] C. J. Harmer, F. Lebreton, J. Stam, P. T. McGann, and R. M. Hall. (2022). "Complete Genome of the Extensively Antibiotic-Resistant GC1 Acinetobacter baumannii Isolate MRSN 56 Reveals a Novel Route to Fluoroquinolone Resistance". Journal of Antimicrobial Chemotherapy. 77 (7): 1851-1855. 10.1093/jac/dkac115.

  DOI: https://doi.org/10.1093/jac/dkac115

• [65] M. Venkatesan, M. Fruci, L. A. Verellen, T. Skarina, N. Mesa, R. Flick, C. Pham, R. Mahadevan, P. J. Stogios, and A. Savchenko. (2023). "Molecular Mechanism of Plasmid-Borne Resistance to Sulfonamide Antibiotics". Nature Communications. 14 (1): 39778. 10.1038/s41467-023-39778-7.

  DOI: https://doi.org/10.1038/s41467-023-39778-7

• [66] B. P. Alcock, A. R. Raphenya, T. T. Y. Lau, K. K. Tsang, M. Bouchard, A. Edalatmand, W. Huynh, A. L. V. Nguyen, A. A. Cheng, S. Liu, S. Y. Min, A. Miroshnichenko, H. K. Tran, R. E. Werfalli, J. A. Nasir, M. Oloni, D. J. Speicher, A. Florescu, B. Singh, and M. Faltyn. (2020). "CARD 2020: Antibiotic Resistome Surveillance with the Comprehensive Antibiotic Resistance Database". Nucleic Acids Research. 48 (D1): D517-D525. 10.1093/nar/gkz935.

  DOI: https://doi.org/10.1093/nar/gkz935

##plugins.themes.gdThemes.article.info##